Finally, GSEA results screened out several pathways involved in cancer progression, laying a solid foundation for the possible functional roles of CTLA4 or FGFR2 in HNSCC, encouraging more in-depth investigation in the future. The gene discussed is FGFR2; the disease is cancer.